| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/25/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Share | 5.2k | $18.01 | $93.7k | | 07/25/2023 |
| 07/25/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 29k | $1.86 | $53.9k | | 07/25/2023 |
| 07/25/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Share | 16.2k | $19.25 | $311.2k | | 07/25/2023 |
| 07/25/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Share | 7.6k | $19.69 | $150.3k | | 07/25/2023 |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 39k | $10.76 | $419.4k | | 04/01/2023 |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 6.5k | $0.00 | $0 | | 04/01/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.1k | $11.12 | $12k | | 03/16/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 3.7k | $0.00 | $0 | | 03/16/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 1.7k | $0.00 | $0 | | 03/16/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 507 | $11.46 | $5.8k | | 03/16/2023 |
| 11/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Share | 28.4k | $15.18 | $430.5k | | 11/07/2022 |
| 11/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 28.4k | $1.86 | $52.7k | | 11/07/2022 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 507 | $11.44 | $5.8k | | 09/01/2022 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 1.7k | $0.00 | $0 | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 59.9k | $11.97 | $717.4k | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 10k | $0.00 | $0 | | 09/01/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 10k | $0.00 | $0 | | 04/07/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 59.9k | $11.10 | $665.2k | | 04/07/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.7k | $10.98 | $18.5k | | 03/21/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 5.7k | $0.00 | $0 | | 03/21/2022 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 598 | $10.13 | $6.1k | | 03/16/2022 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 1.7k | $0.00 | $0 | | 03/16/2022 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 6.9k | $0.00 | $0 | | 09/02/2021 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 41.4k | $12.97 | $537k | | 09/02/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 3.7k | $0.00 | $0 | | 03/20/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 5.7k | $0.00 | $0 | | 03/20/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 41.4k | $22.89 | $947.6k | | 03/16/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 6.9k | $0.00 | $0 | | 03/16/2021 |
| 09/10/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 50k | $15.50 | $775k | | 09/10/2020 |
| 03/13/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 50k | $15.52 | $776k | | 03/13/2020 |
| 02/27/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 12k | $1.86 | $22.3k | | 02/27/2020 |
| 02/20/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 9.8k | $3.80 | $37.3k | | 02/19/2020 |
| 02/20/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 8.7k | $18.91 | $164.3k | | 02/19/2020 |
| 02/20/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 1.1k | $19.32 | $21.6k | | 02/19/2020 |
| 02/19/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 22.5k | $18.27 | $410.7k | | 02/19/2020 |
|